Role of T cells in malnutrition and obesity

Frontiers in Immunology

Volumn 5, Issue AUG, 2014, Pages

  Gerriets, Valerie A ^a   MacIver, Nancie J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Inflammation; Leptin; Malnutrition; Obesity; T cells

Indexed keywords

C REACTIVE PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CHEMOKINE RECEPTOR CXCR3; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLUCOSE TRANSPORTER 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAMMALIAN TARGET OF RAPAMYCIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CELL METABOLISM; CELL MIGRATION; CELLULAR IMMUNITY; HUMAN; IMMUNE DEFICIENCY; INFECTION; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MACROPHAGE; MALNUTRITION; NONHUMAN; NUTRITIONAL STATUS; OBESITY; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL;

EID: 84921406001     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00379     Document Type: Article

References (127)

1. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA (2004) 291:2847-50. doi:10.1001Jjama.291.23.2847
2. Li Z, Bowerman S, Heber D. Health ramifications of the obesity epidemic. Surg Clin North Am (2005) 85:681-701. doi:10.1016Jj.suc.2005.04.006
3. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA (2001) 286:1195-200. doi:10.1001Jjama.286.10.1195
4. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care (2001) 24:1936-40. doi:10.2337Jdiacare.24.11.1936
5. Harpsoe MC, Basit S, Andersson M, Nielsen NM, Frisch M, Wohlfahrt J, et al. Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort. Int J Epidemiol (2014) 43:843-55. doi:10.1093JijeJ dyuO45
6. Duntas LH, Biondi B. The interconnections between obesity, thyroid function, and autoimmunity: the multifold role of leptin. Thyroid (2013) 23:646-53. doi:10.1089Jthy.2011.0499
7. Lukens JR, Dixit VD, Kanneganti TD. Inflammasome activation in obesityrelated inflammatory diseases and autoimmunity. Discov Med (2011) 12:65-74.
8. Schottenfeld D, Beebe-Dimmer JL, Buffler PA, Omenn GS. Current perspective on the global and United States cancer burden attributable to lifestyle and environmental risk factors. Annu Rev Public Health (2013) 34:97-117. doi: 10.1146Jannurev-publhealth-031912-114350
9. Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist (2010) 15:556-65. doi:10.1634Jtheoncologist.2009-0285
10. Falagas ME, Kompoti M. Obesity and infection. Lancet Infect Dis (2006) 6:438-46. doi:10.1016JS1473-3099(06)70523-0
11. Milner JJ, Beck MA. The impact of obesity on the immune response to infection. ProcNutrSoc (2012) 71:298-306. doi:10.1017JS0029665112000158
12. Shu CJ, Benoist C, Mathis D. The immune system's involvement in obesitydriven type 2 diabetes. Semin Immunol (2012) 24:436-42. doi:10.1016Jj.smim. 2012.12.001
13. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol (2011) 29:415-45. doi:10.1146Jannurev-immunol-031210-101322
14. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 259:87-91. doi:10.1126Jscience.7678183
15. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature (1997) 389:610-4. doi:10.1038J39335
16. Ventre J, Doebber T, Wu M, MacNaul K, Stevens K, Pasparakis M, et al. Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice. Diabetes (1997) 46:1526-31. doi:10.2337Jdiabetes. 46.9.1526
17. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 286:327-34. doi:10.1001Jjama.286.3.327
18. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest (2003) 112:1821-30. doi:10.1172JJCI19451
19. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest (2003) 112:1796-808. doi:10.1172JJCI19246
20. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest (2007) 117:175-84. doi:10.1172JJCI29881
21. Lumeng CN, Deyoung SM, Bodzin JL, Saltiel AR. Increased inflammatory properties of adipose tissue macrophages recruited during diet-induced obesity. Diabetes (2007) 56:16-23. doi:10.2337Jdb06-1076
22. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, et al. IKKbeta links inflammation to obesity-induced insulin resistance. Nat Med (2005) 11:191-8. doi:10.1038Jnmll85
23. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, et al. A central role for JNK in obesity and insulin resistance. Nature (2002) 420:333-6. doi:10.1038Jnature01137
24. Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med (2012) 18:363-74. doi:10.1038Jnm.2627
25. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol (2010) 72:219-46. doi:10.1146Jannurev-physiol-021909-135846
26. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest (2005) 115:1111-9. doi:10.1172JJCI25102
27. Christiansen T, Richelsen B, Bruun JM. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Land) (2005) 29:146-50. doi:10.1038Jsj.ijo.0802839
28. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG. Ablation of CDllc-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab (2008) 8:301-9. doi:10.1016Jj.cmet.2008.08.015
29. Huh JY, Park YJ, Ham M, Kim JB. Crosstalk between adipocytes and immune cells in adipose tissue inflammation and metabolic dysregulation in obesity. Mol Cells (2014) 37:365-71. doi:10.14348Jmolcells.2014.0074
30. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med (2009) 15:914-20. doi:10.1038Jnm.l964
31. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med (2009) 15:930-9. doi:10.1038Jnm.2002
32. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med (2009) 15:921-9. doi:10.1038Jnm.2001
33. Yang H, Youm YH, Vandanmagsar B, Ravussin A, Gimble JM, Greenway F, et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol (2010) 185:1836-45. doi: 10.4049Jjimmunol.l000021
34. Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH, et al. Interferon-gamma, a Thl cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res (2008) 103:467-76. doi:10.1161J CIRCRESAHA.108.177105
35. O'Rourke RW, White AE, Metcalf MD, Winters BR, Diggs BS, Zhu X, et al. Systemic inflammation and insulin sensitivity in obese IFN-gamma knockout mice. Metabolism (2012) 61:1152-61. doi:10.1016Jj.metabol.2012.01.018
36. Khan IM, Dai Perrard XY, Perrard JL, Mansoori A, Smith CW, Wu H, et al. Attenuated adipose tissue and skeletal muscle inflammation in obese mice with combined CD4+ and CD8+ T cell deficiency. Atherosclerosis (2014) 233:419-28. doi:10.1016Jj.atherosclerosis.2014.01.011
37. Stolarczyk E, Vong CT, Perucha E, Jackson I, Cawthorne MA, Wargent ET, et al. Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor T-bet. Cell Metab (2013) 17:520-33. doi:10.1016Jj.cmet.2013.02.019
38. Kim KY, Jeong HJ, Kim HM. The role of T-bet in obesity: lack of T-bet causes obesity in male mice. J Nutr Biochem (2013) 24:240-7. doi:10.1016Jj.jnutbio. 2012.05.010
39. Stolarczyk E, Lord GM, Howard JK. The immune cell transcription factor T-bet: anovel metabolic regulator. Adipocyte (2014) 3:58-62. doi:10.4161Jadip. 26220
40. Winer S, Paltser G, Chan Y, Tsui H, Engleman E, Winer D, et al. Obesity predisposes to Thl7 bias. Eur JImmunol (2009) 39:2629-35. doi:10.1002Jeji. 200838893
41. Sumarac-Dumanovic M, Stevanovic D, Ljubic A, Jorga J, Simic M, Stamenkovic-Pejkovic D, et al. Increased activity of interleukin-23Jinterleukin-17 proinflammatory axis in obese women. Int J Obes (Land) (2009) 33:151-6. doi: 10.1038Jijo.2008.216
42. Jagannathan-Bogdan M, McDonnell ME, Shin H, Rehman Q, Hasturk H, Apovian CM, et al. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol (2011) 186:1162-72. doi:10.4049Jjimmunol.l002615
43. Fabbrini E, Cella M, McCartney SA, Fuchs A, Abumrad NA, Pietka TA, et al. Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterology (2013) 145(366-74):el-3. doi:10.1053Jj.gastro.2013.04.010
44. Ahmed M, Gaffen SL. IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev (2010) 21:449-53. doi:10.1016Jj.cytogfr.2010.10.005
45. Zuniga LA, Shen WJ, Joyce-Shaikh B, Pyatnova EA, Richards AG, Thorn C, et al. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol (2010) 185:6947-59. doi:10.4049Jjimmunol.l001269
46. Pini M, Fantuzzi G. Enhanced production of IL-17A during zymosaninduced peritonitis in obese mice. J Leukoc Biol (2010) 87:51-8. doi:10.1189J jlb.0309188
47. Rausch ME, Weisberg S, Vardhana P, Tortoriello DV. Obesity in C57BLJ6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int JObes (Lond) (2008) 32:451-63. doi:10.1038Jsj.ijo.0803744
48. Jiang E, Perrard XD, Yang D, Khan IM, Perrard JL, Smith CW, et al. Essential role of CD 1 la in CD8+ T-cell accumulation and activation in adipose tissue. Arterioscler Thromb VascBiol (2014) 34:34-43. doi:10.1161JATVBAHA.l 13.302077
49. Winer DA, Winer S, Chng MH, Shen L, Engleman EG. B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance. Cell Mol Life Sci (2014) 71:1033-43. doi:10.1007Js00018-013-1486-y
50. Winer DA, Winer S, Shen L, Wadia PP, Yantha J, Paltser G, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med (2011) 17:610-7. doi:10.1038Jnm.2353
51. DeFuria J, Belkina AC, Jagannathan-Bogdan M, Snyder-Cappione J, Carr JD, Nersesova YR, et al.B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc Natl Acad Sci USA (2013) 110:5133-8. doi:10.1073Jpnas.l215840110
52. Wagner NM, Brandhorst G, Czepluch F, Lankeit M, Eberle C, Herzberg S, et al. Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. Obesity (Silver Spring) (2013) 21:461-8. doi:10.1002Joby.20087
53. Cipolletta D, Feuerer M, Li A, Kamei N, Lee J, Shoelson SE, et al. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature (2012) 486:549-53. doi:10.1038Jnaturelll32
54. Han JM, Patterson SJ, Speck M, Ehses JA, Levings MK. Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity. J Immunol (2014) 192:623-9. doi: 10.4049Jjimmunol. 1302181
55. Rocha VZ, Folco EJ, Ozdemir C, Sheikine Y, Christen T, Sukhova GK, et al. CXCR3 controls T-cell accumulation in fat inflammation. Arterioscler Thromb Vase Biol (2014) 34:1374-81. doi:10.1161JATVBAHA.113.303133
56. Deiuliis JA, Oghumu S, Duggineni D, Zhong J, Rutsky J, Banerjee A, et al. CXCR3 modulates obesity-induced visceral adipose inflammation and systemic insulin resistance. Obesity (Silver Spring) (2014) 22:1264-74. doi:10. 1002Joby.20642
57. Wu H, Ghosh S, Perrard XD, Feng L, Garcia GE, Perrard JL, et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Cireulation (2007) 115:1029-38. doi:10.1161JCIRCULATIONAHA.106.638379
58. Kitade H, Sawamoto K, Nagashimada M, Inoue H, Yamamoto Y, Sai Y, et al. CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1JM2 status. Diabetes (2012) 61:1680-90. doi:10.2337Jdbll-1506
59. Morris DL, Cho KW, Delproposto JL, Oatmen KE, Geletka LM, Martinez-Santibanez G, et al. Adipose tissue macrophages function as antigen-presenting cells and regulate adipose tissue CD4+ T cells in mice. Diabetes (2013) 62:2762-72. doi: 10.2337Jdb 12-1404
60. Ioan-Facsinay A, Kwekkeboom JC, Westhoff S, Giera M, Rombouts Y, van Harmelen V, et al. Adipocyte-derived lipids modulate CD4+ T-cell function. Eur J Immunol (2013) 43:1578-87. doi:10.1002Jeji.201243096
61. Deng T, Lyon C J, Minze LJ, Lin J, Zou J, Liu JZ, et al. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. CellMetab (2013) 17:411-22. doi:10.1016Jj.cmet.2013.02.009
62. Samaras K, Viardot A, Botelho NK, Jenkins A, Lord RV. Immune cell-mediated inflammation and the early improvements in glucose metabolism after gastric banding surgery. Diabetologia (2013) 56:2564-72. doi:10.1007Js00125-013-3033-7
63. Kawanishi N, Mizokami T, Yano H, Suzuki K. Exercise attenuates Ml macrophages and CD8+ T cells in the adipose tissue of obese mice. Med Sci Sports Exerc (2013) 45:1684-93. doi:10.1249JMSS.0b013e31828ff9c6
64. Lasselin J, Magne E, Beau C, Ledaguenel P, Dexpert S, Aubert A, et al. Adipose inflammation in obesity: relationship with circulating levels of inflammatory markers and association with surgery-induced weight loss. J Clin Endocrinol Metab (2014) 99:E53-61. doi:10.1210Jjc.2013-2673
65. Dominguez H, Storgaard H, Rask-Madsen C, Steffen Hermann T, Ihlemann N, Baunbjerg Nielsen D, et al. Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes. J Vasc Res (2005)42:517-25. doi:10.1159J000088261
66. Gonzalez-Gay MA, De Matias JM, Gonzalez-Juanatey C, Garcia-Porrua C, Sanchez-Andrade A, Martin J, et al. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol (2006) 24:83-6.
67. Stanley TL, Zanni MV, Johnsen S, Rasheed S, Makimura H, Lee H, et al. TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J Clin Endocrinol Metab (2011) 96:E146-50. doi:10.1210Jjc.2010-1170
68. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKbeta. Science (2001) 293:1673-7. doi:10.1126Jscience.l061620
69. Kim JK, Kim YJ, Fillmore JJ, Chen Y, Moore I, Lee J, et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest (2001) 108:437-46. doi:10.1172JJCI200111559
70. Kim MS, Yamamoto Y, Kim K, Kamei N, Shimada T, Liu L, et al. Regulation of diet-induced adipose tissue and systemic inflammation by salicylates and pioglitazone. PLoS One (2013) 8:e82847. doi:10.1371Jjournal.pone.0082847
71. Goldfine AB, Conlin PR, Halperin F, Koska J, Permana P, Schwenke D, et al. A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance. Diabetologia (2013) 56:714-23. doi:10.1007Js00125-012-2819-3
72. Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B, et al. Interleukin-1 -receptor antagonist in type 2 diabetes mellitus. N Engl J Med (2007) 356:1517-26. doi:10.1056JNEJMoa065213
73. Montes VN, Turner MS, Subramanian S, Ding Y, Hayden-Ledbetter M, Slater S, et al. T cell activation inhibitors reduce CD8+ T cell and pro-inflammatory macrophage accumulation in adipose tissue of obese mice. PLoS One (2013) 8:e67709. doi:10.1371Jjoumal.pone.0067709
74. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al. Maternal and child undernutrition and overweight in low-income and middleincome countries. Lancet (2013) 382:427-51. doi:10.1016JS0140-6736(13) 60937-X
75. Neumann CG, Gewa C, Bwibo NO. Child nutrition in developing countries. Pediatr Ann (2004) 33:658-74. doi:10.3928J0090-4481-20041001-09
76. Hickman D, Jones MK, Zhu S, Kirkpatrick E, Ostrov DA, Wang X, et al. The effect of malnutrition on norovirus infection. MBio (2014) 5:e01032-13. doi:10.1128JmBio.01032-13
77. Caulfield LE, de Onis M, Blossner M, Black RE. Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles. Am J Clin Nutr (2004) 80:193-8.
78. Laus MF, Vales LD, Costa TM, Almeida SS. Early postnatal protein-calorie malnutrition and cognition: a review of human and animal studies. Int J Environ Res Public Health (2011) 8:590-612. doi:10.3390Jijerph8020590
79. Kar BR, Rao SL, Chandramouli BA. Cognitive development in children with chronic protein energy malnutrition. Behav Brain Fund (2008) 4:31. doi:10.1186J1744-9081-4-31
80. Antwi A. Assessment and management of severe malnutrition in children. West AfrJMed (2011) 30:11-8.
81. Schlaudecker EP, Steinhoff MC, Moore SR. Interactions of diarrhea, pneumonia, and malnutrition in childhood: recent evidence from developing countries. CurrOpin InfectDis (2011) 24:496-502. doi:10.1097JQCO.0b013e328349287d
82. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 69:491-7.
83. von Haehling S, Anker SD. Cachexia as major underestimated unmet medical need: facts and numbers. Int J Cardiol (2012) 161:121-3. doi:10.1016Jj.ijcard. 2012.09.213
84. Howard JK, Lord GM, Matarese G, Vendetti S, Ghatei MA, Ritter MA, et al. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in obJob mice. J Clin Invest (1999) 104:1051-9. doi:10.1172JJCI6762
85. Procaccini C, De Rosa V, Galgani M, Carbone F, Cassano S, Greco D, et al. Leptin-induced mTOR activation defines a specific molecular and transcriptional signature controlling CD4+ effector T cell responses. J Immunol (2012) 189:2941-53. doi:10.4049Jjimmunol.l200935
86. Saucillo DC, Gerriets VA, Sheng J, Rathmell JC, Maciver NJ. Leptin metabolically licenses T cells for activation to link nutrition and immunity. J Immunol (2014) 192:136-44. doi:10.4049Jjimmunol.l301158
87. Pena-CruzV, Reiss CS, Mclntosh K. Sendai virus infection of mice with protein malnutrition. J Virol (1989) 63:3541-4.
88. Taylor AK,Cao W,Vora KP,De La Cruz J,Shieh WJ,Zaki SR,et al. Protein energy malnutrition decreases immunity and increases susceptibility to influenza infection in mice. J Infect Dis (2013) 207:501-10. doi:10.1093JinfdisJjis527
89. NajeraO, Gonzalez C, Toledo G, Lopez L, Ortiz R. Flow cytometry study of lymphocyte subsets in malnourished and well-nourished children with bacterial infections. Clin Diagn Lab Immunol (2004) 11:577-80.
90. Mengheri E, Nobili F, Crocchioni G, Lewis JA. Protein starvation impairs the ability of activated lymphocytes to produce interferon-gamma. J Interferon Res (1992) 12:17-21. doi:10.1089Jjir.l992.12.17
91. Gonzalez-Torres C, Gonzalez-Martinez H, Miliar A, Najera O, Graniel J, Firo V, et al. Effect of malnutrition on the expression of cytokines involved in Thl cell differentiation. Nutrients (2013) 5:579-93. doi:10.3390Jnu5020579
92. Gonzalez-Martinez H, Rodriguez L, Najera O, Cruz D, Miliar A, Dominguez A, et al. Expression of cytokine mRNA in lymphocytes of malnourished children. J Clin Immunol (2008) 28:593-9. doi:10.1007Jsl0875-008-9204-5
93. Jacobs SR, Herman CE, Maciver NJ, Wofford JA, Wieman HL, Hammen JJ, et al. Glucose uptake is limiting in T cell activation and requires CD28-mediated AKT-dependent and independent pathways. J Immunol (2008) 180:4476-86. doi: 10.4049Jjimmunol. 180.7.4476
94. Wang R, Dillon CP, Shi LZ, Milasta S, Carter R, Finkelstein D, et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity (2011) 35:871-82. doi:10.1016Jj.immuni.2011.09.021
95. Cham CM, Gajewski TE Glucose availability regulates IFN-gamma production and p70S6 kinase activation in CD8+ effector T cells. J Immunol (2005) 174:4670-7. doi:10.4049Jjimmunol.l74.8.4670
96. Xia CQ, Chernatynskaya AV, Looney B,Wan S, Clare-Salzler MJ. Anti-CD3 antibody treatment induces hypoglycemia and super tolerance to glucose challenge in mice through enhancing glucose consumption by activated lymphocytes. J Immunol Res (2014) 2014:326708. doi:10.1155J2014J326708
97. Savy M, Edmond K, Fine PE, Hall A, Hennig BJ, Moore SE, et al. Landscape analysis of interactions between nutrition and vaccine responses in children. J Nutr (2009) 139:2154S-218S. doi:10.3945Jjn.l09.105312
98. Iyer SS, Chatraw JH, Tan WG, Wherry EJ, Becker TC, Ahmed R, et al. Protein energy malnutrition impairs homeostatic proliferation of memory CD8 T cells. J Immunol (2012) 188:77-84. doi:10.4049Jjimmunol.l004027
99. Chatraw JH, Wherry EJ, Ahmed R, Kapasi ZF. Diminished primary CD8 T cell response to viral infection during protein energy malnutrition in mice is due to changes in microenvironment and low numbers of viral-specific CD8 T cell precursors. J Nutr (2008) 138:806-12.
100. Chan J, Tian Y, Tanaka KE, Tsang MS, Yu K, Salgame P, et al. Effects of protein calorie malnutrition on tuberculosis in mice. Proc Natl Acad Sci USA (1996) 93:14857-61. doi:10.1073Jpnas.93.25.14857
101. Najera O, Gonzalez C, Toledo G, Lopez L, Cortes E, Betancourt M, et al. CD45RA and CD45RO isoforms in infected malnourished and infected wellnourished children. CHn Exp Immunol (2001) 126:461-5. doi:10.1046Jj.l365-2249.2001.01694.x
102. Murphy ED, Roths JB. AY chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum (1979) 22:1188-94. doi:10.1002Jart.l780221105
103. Kubo C, Gajar A, Johnson BC, Good RA. The effects of dietary restriction on immune function and development of autoimmune disease in BXSB mice. Proc NatlAcadSci USA (1992) 89:3145-9. doi:10.1073Jpnas.89.7.3145
104. Piccio L, Stark JL, Cross AH. Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis. JLeukoc Biol (2008) 84:940-8. doi:10. 1189Jjlb.0208133
105. Sanna V, Di Giacomo A, La Cava A, Lechler RI, Fontana S, Zappacosta S, et al. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest (2003) 111:241-50. doi:10.1172JJCI200316721
106. Esquifino Al, Cano P, Jimenez V, Cutrera RA, Cardinali DP. Experimental allergic encephalomyelitis in male Lewis rats subjected to calorie restriction. J Physiol Biochem (2004) 60:245-52. doi:10.1007JBF03167069
107. Kafami L, Raza M, Razavi A, Mirshafiey A, Movahedian M, Khorramizadeh MR. Intermittent feeding attenuates clinical course of experimental autoimmune encephalomyelitis in C57BLJ6 mice. Avicenna J Med Biotechnol (2010) 2:47-52.
108. Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. MolAspects Med (2012) 33:35-45. doi:10.1016Jj.mam.2011.10.012
109. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, et al. Role of leptin in the neuroendocrine response to fasting. Nature (1996) 382:250-2. doi:10.1038J382250a0
110. Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab (1996) 81:3419-23. doi:10.1210Jjc.81.9.3419
111. Bartz S, Mody A, Hornik C, Bain J, Muehlbauer M, Kiyimba T, et al. Severe acute malnutrition in childhood: hormonal and metabolic status at presentation, response to treatment, and predictors of mortality. J Clin Endocrinol Metab (2014) 99(6):2128-37. doi:10.1210Jjc.2013-4018
112. Harris RB, Zhou J, Redmann SM Jr., Smagin GN, Smith SR, Rodgers E, et al. A leptin dose-response study in obese (obJob) and lean (+J?) mice. Endocrinology (1998) 139:8-19. doi:10.1210Jendo.l39.1.5675
113. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature (1998) 394:897-901. doi:10.1038J29795
114. White SJ, Taylor MJ, Hurt RT, Jensen MD, Poland GA. Leptin-based adjuvants: an innovative approach to improve vaccine response. Vaccine (2013) 31:1666-72. doi:10.1016Jj.vaccine.2013.01.032
115. Rodriguez L, Graniel J, Ortiz R. Effect of leptin on activation and cytokine synthesis in peripheral blood lymphocytes of malnourished infected children. Clin Exp Immunol (2007) 148:478-85. doklO.l 11 lJj.1365-2249.2007.03361.x
116. Cauchard S, Bermudez-Humaran LG, Blugeon S, Laugier C, Langella P, Cauchard J. Mucosal co-immunization of mice with recombinant lactococci secreting VapA antigen and leptin elicits a protective immune response against Rhodococcus equi infection. Vaccine (2011) 30:95-102. doi:10.1016Jj.vaccine. 2011.10.026
117. Wehrens A, Aebischer T, Meyer TF, Wai Duck AK. Leptin receptor signaling is required for vaccine-induced protection against Helicobacterpylori. Helicobacter (2008) 13:94-102. doi:10.1111Jj.l523-5378.2008.00591.x
118. Wang B, Chandrasekera PC, Pippin JJ. Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes. Curr Diabetes Rev (2014) 10:131-45. doi:10.2174J1573399810666140508121012
119. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA, et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci USA (2004) 101:3329-35. doi:10.1073Jpnas.0308061100
120. Tamas P, Hawley SA, Clarke RG, Mustard KJ, Green K, Hardie DG, et al. Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes. J Exp Med (2006) 203:1665-70. doi: 10.1084Jjem.20052469
121. Maclver NJ, Blagih J, Saucillo DC, Tonelli L, Griss T, Rathmell JC, et al. The liver kinase Bl is a central regulator of T cell development, activation, and metabolism. JImmunol (2011) 187:4187-98. doi:10.4049Jjimmunol.H00367
122. Tamas P, Macintyre A, Finlay D, Clarke R, Feijoo-Carnero C, Ashworth A, et al. LKB1 is essential for the proliferation of T-cell progenitors and mature peripheral T cells. Eur J Immunol (2010) 40:242-53. doi:10.1002Jeji.200939677
123. Cao Y,Li H,Liu H.Zheng C,Ji H,Liu X.TheserineJthreoninekinaseLKB1 controls thymocyte survival through regulation of AMPK activation and Bcl-XL expression. Cell Res (2010) 20:99-108. doi:10.1038Jcr.2009.141
124. Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, Xiao B, et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity (2009) 30:832-44. doi:10.1016Jj.immuni.2009.04.014
125. Delgoffe GM, Pollizzi KN, Waickman AT, Heikamp E, Meyers DJ, Horton MR, et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORCl and mTORC2. Nat Immunol (2011) 12:295-303. doi:10.1038Jni.2005
126. Zeng H, Yang K, Cloer C, Neale G, Vogel P, Chi H. mTORCl couples immune signals and metabolic programming to establish T(reg)-cell function. Nature (2013) 499:485-90. doi:10.1038Jnaturel2297
127. Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, Maclver NJ, Mason EF, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol (2011) 186:3299-303. doi:10.4049Jjimmunol.l003613